1998
DOI: 10.1016/s1079-2104(98)90063-4
|View full text |Cite
|
Sign up to set email alerts
|

Permeation of 17β-estradiol through human vaginal and buccal mucosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
27
0

Year Published

2000
2000
2014
2014

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(29 citation statements)
references
References 14 publications
2
27
0
Order By: Relevance
“…Although this route offers a gender-specific treatment of systemic or local, female-related conditions (2,3), the merits of vaginal administration such as the avoidance of hurdles associated with per-oral or parenteral application (i.e., drug hepatotoxicity, first-pass drug metabolism, drug plasma concentrations fluctuations, side effects, inconvenience, irritation of gastrointestinal mucosa; 2) enable prolonged dosing with lower daily doses of drugs applied in controlled-release delivery systems (1). Achieving comparable pharmacodynamic effects by vaginal route as by per-oral drug delivery provides indirect proof of effective drug absorption through vaginal mucosa owing to its high absorptive surface area, rich blood supply, significantly diminished expression of phase I and II metabolizing enzymes and transporters, and sufficient permeability to drugs (4)(5)(6)(7)(8)(9)(10).…”
Section: Introductionmentioning
confidence: 99%
“…Although this route offers a gender-specific treatment of systemic or local, female-related conditions (2,3), the merits of vaginal administration such as the avoidance of hurdles associated with per-oral or parenteral application (i.e., drug hepatotoxicity, first-pass drug metabolism, drug plasma concentrations fluctuations, side effects, inconvenience, irritation of gastrointestinal mucosa; 2) enable prolonged dosing with lower daily doses of drugs applied in controlled-release delivery systems (1). Achieving comparable pharmacodynamic effects by vaginal route as by per-oral drug delivery provides indirect proof of effective drug absorption through vaginal mucosa owing to its high absorptive surface area, rich blood supply, significantly diminished expression of phase I and II metabolizing enzymes and transporters, and sufficient permeability to drugs (4)(5)(6)(7)(8)(9)(10).…”
Section: Introductionmentioning
confidence: 99%
“…All the specimens were placed in a transport fluid, prepared as previously described and transferred to our laboratory within I h (17). Excess connective and adipose tissue were carefully removed from all specimens, and hereafter these were snap-frozen in liquid nitrogen and stored at -85°C.…”
Section: Human Vaginal Mucosamentioning
confidence: 99%
“…The frozen samples were thawed in PBS (phosphate-buffered saline) for at least 10 min. Fresh and thawed tissue disks were mounted in flow-through diffusion cells (exposed areas 0.039 B 0.001 SD cm 2 ) as previously described [13,14], and permeation studies were performed on 7 tissue replicates for each patient. Prior to commencement of the experiment, tissue disks were equilibrated for 10 min with PBS (pH 7.9) at 20°C in both the donor and receiver compartments of the diffusion cells.…”
Section: Permeability Experimentsmentioning
confidence: 99%
“…The objective of this study was to determine the barrier properties to water of fresh and frozen human skin treated with two different barrier creams containing a waterrepellant and a water-attracting base, using a continuous flow-through diffusion apparatus for small tissue samples, previously employed for determining the permeability of mucosae and synthetic membranes to a variety of compounds [13][14].…”
mentioning
confidence: 99%